Skip to main content
Terug
Watch Compare

ALX ONCOLOGY HOLDINGS INC

Datakwaliteit: 83%
ALXO
Nasdaq Manufacturing Chemicals
€ 1,70
€ 0,00 (0,00%)
Marktkapitalisatie: 223,73 M
Prijs
€ 1,70
Marktkapitalisatie
223,73 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Debt/Equity of 0,24 — conservative balance sheet
Negative free cash flow of -84,35 M

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-186,23%
Onder sectorgemiddelde (-53,53%)
ROIC-125,01%
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
0,24
Onder sectorgemiddelde (0,31)
Current Ratio2,40
Interest Coverage-64,93

Waardering

PE (TTM)
-2,20
Onder sectorgemiddelde (-1,48)
P/B Ratio4,99
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -2,2 -1,5
P/B 5,0 1,6
ROE % -186,2 -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E 0,2 0,3

Koersdoel Analisten

5 analisten
Buy
Huidig
€ 1,70
+170.6%
Koersdoel
€ 4,60
€ 4,00
€ 4,00
€ 6,00
Vooruitzicht
Forward K/W -2,77
Forward WPA -€ 0,61
Omzet Sch. 0,0

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 0,61
-€ 0,69 – -€ 0,54
 0,0 2
FY2026 -€ 0,65
-€ 0,65 – -€ 0,65
 0,0 1

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 0,32 -€ 0,37 -15,5%
Q32025 -€ 0,37 -€ 0,41 -10,1%
Q22025 -€ 0,31 -€ 0,44 -43,1%
Q12025 -€ 0,31 -€ 0,48 -54,5%

ETFs Holding This Stock

BRUSX BRUSX
0,02% weight

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -101,70 M
ROE -186,23% ROA -114,24%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -84,35 M
ROIC -125,01% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,24 Current Ratio 2,40
Interest Coverage -64,93 Asset Turnover N/A
Working Capital 38,79 M Tangible Book Value 44,80 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -2,20 Forward P/E N/A
P/B Ratio 4,99 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -37,70%
Market Cap 223,73 M Enterprise Value 210,89 M
Per Share
EPS (Diluted TTM) -1,90 Revenue / Share N/A
FCF / Share -0,64 OCF / Share -0,64
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 82,95%
SBC-Adj. FCF -101,18 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue — — — 0,0 1,18 M
Net Income -101,70 M -134,85 M -160,81 M -123,48 M -83,46 M
EPS (Diluted) -1,90 -2,58 -3,74 -3,03 —
Gross Profit — — — — —
Operating Income -104,02 M -142,47 M -170,28 M -127,44 M -83,56 M
EBITDA — — — — —
R&D Expenses 77,00 M 116,37 M 141,80 M 98,40 M 60,17 M
SG&A Expenses — — — — —
D&A 706.000,0 872.000,0 836.000,0 342.000,0 51.000,0
Interest Expense 1,60 M 1,73 M 1,57 M — —
Income Tax 0,0 64.000,0 64.000,0 64.000,0 -21.000,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 59,05 M 147,78 M 242,55 M 306,49 M 380,18 M
Total Liabilities 33,07 M 34,16 M 52,84 M 43,03 M 17,13 M
Shareholders' Equity 25,98 M 113,62 M 189,71 M 263,46 M 363,05 M
Total Debt 10,17 M 10,60 M 10,60 M 10,60 M —
Cash & Equivalents 16,37 M 17,57 M 22,41 M 48,82 M 363,67 M
Current Assets 50,73 M 134,35 M 188,66 M 270,97 M 367,02 M
Current Liabilities 24,55 M 18,50 M 36,00 M 28,33 M 15,30 M